ANDA 77407, held by Taro. Sodium Chloride.
As of Nov 15, 2026, ANDA 77407 (Sodium Chloride 0.9% In Plastic Container), held by Taro, was first approved by FDA on Aug 11, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 11, 2006 | Original application | Approved |
| Sodium Chloride 0.9% In Plastic Container45MG/5ML (9MG/ML) · solution;injection | Sodium Chloride | Rx |
| Sodium Chloride 0.9% In Plastic Container90MG/10ML (9MG/ML) · solution;injection | Sodium Chloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
